Skinvisible Inc (SKVI)

[NetworkNewsWire]

SKVI Takes Aim at the Global Skincare Market

Research and development company Skinvisible, Inc. (OTCQB: SKVI) has set its sights on the burgeoning global markets for skincare, dermatology and over-the-counter products. An article discussing this reads: “Skinvisible, Inc. (OTCQB: SKVI) is targeting a global skincare market that’s projected to reach $135 billion by 2021 (http://nnw.fm/61ruV). SKVI also sees a worldwide dermatology market of $80 billion, plus a $30 billion worldwide over-the-counter (OTC) market (http://nnw.fm/0NaOC). It has already completed the development of 40 products, received numerous technology and product patents and is now ready to monetize its investment. In the U.S. alone, skincare is projected to reach $10.7 billion by 2018, and the global skincare market is seen growing at a compound annual growth rate (CAGR) of 3.8% from 2016-2021, according to MarketResearch.com (http://nnw.fm/3Uy9z).”

To view the full article, visit http://nnw.fm/Lr1fL

About Skinvisible Pharmaceuticals, Inc.

Skinvisible Pharmaceuticals is a research and development company that licenses its proprietary formulations made with Invisicare®, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time, allowing for the controlled release of actives. For more information, visit www.skinvisible.com or www.invisicare.com.